| C065719 | 10-hydroxywarfarin | 10-hydroxywarfarin binds to and results in decreased activity of CYP2C9 protein | 20429590 |
| C065719 | 10-hydroxywarfarin | [10-hydroxywarfarin binds to and results in increased activity of NR1I2 protein] which results in increased expression of CYP2C9 mRNA | 20735727 |
| C065719 | 10-hydroxywarfarin | 10-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin] | 20429590 |
| C046783 | 11,12-epoxy-5,8,14-eicosatrienoic acid | "CYP2C9 protein results in increased chemical synthesis of 11,12-epoxy-5,8,14-eicosatrienoic acid" | 12675279 |
| C046783 | 11,12-epoxy-5,8,14-eicosatrienoic acid | "Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased chemical synthesis of 11,12-epoxy-5,8,14-eicosatrienoic acid]" | 12675279 |
| C495657 | 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | "CYP2C9 protein results in increased chemical synthesis of 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane" | 9733665 |
| C026486 | 1,2,5,6-dibenzanthracene | "CYP2C9 protein results in increased metabolism of 1,2,5,6-dibenzanthracene" | 8638931 |
| C026486 | 1,2,5,6-dibenzanthracene | "[CYP2C9 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-3,4-dihydrodiol" | 8638931 |
| C517214 | 12-hydroxyellipticine | CYP2C9 protein mutant form results in increased chemical synthesis of 12-hydroxyellipticine | 22917556 |
| C439392 | 1-(2-methyl-4-methoxyphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline | "CYP2C9 protein results in decreased methylation of 1-(2-methyl-4-methoxyphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline" | 15585365 |
| C585955 | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | Ketoconazole affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| C585955 | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | [NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | 24120545 |
| C585955 | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | Quercetin inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| C585955 | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| C585955 | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | Tranylcypromine affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| C517215 | 13-hydroxyellipticine | CYP2C9 protein mutant form results in increased chemical synthesis of 13-hydroxyellipticine | 22917556 |
| C046782 | 14,15-epoxy-5,8,11-eicosatrienoic acid | "CYP2C9 protein results in increased chemical synthesis of 14,15-epoxy-5,8,11-eicosatrienoic acid" | 12675279 |
| C046782 | 14,15-epoxy-5,8,11-eicosatrienoic acid | "Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased chemical synthesis of 14,15-epoxy-5,8,11-eicosatrienoic acid]" | 12675279 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "[Anisomycin co-treated with 1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with NR1I3 protein] results in increased expression of CYP2C9 mRNA" | 23539296 |
| C090768 | 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene | "1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene results in increased activity of CYP2C9 protein" | 29285606 |
| C090768 | 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene | "CYP2C9 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene" | 29285606 |
| C090768 | 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene | "[CYP2C9 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene] which results in increased abundance of 1-(4-hydroxyphenyl)-1,2-diphenyl-1-butene metabolite" | 29285606 |
| C035342 | 1,4-naphthoquinone | "CYP2C9 protein results in increased abundance of 1,4-naphthoquinone" | 16243959 |
| C558737 | 1-(6-((2-(dimethylamino)ethyl)(methyl)amino)-1,3-dimethyl-1H-pyrazolo(3,4-b)pyridine-5-carbonyl)-3-(3-isopropoxyphenyl)urea | "1-(6-((2-(dimethylamino)ethyl)(methyl)amino)-1,3-dimethyl-1H-pyrazolo(3,4-b)pyridine-5-carbonyl)-3-(3-isopropoxyphenyl)urea affects the activity of CYP2C9 protein" | 21341682 |
| C486136 | 16-O-demethylaconitine | [Amiodarone results in decreased activity of CYP2C9 protein] which results in decreased chemical synthesis of 16-O-demethylaconitine | 21277363 |
| C486136 | 16-O-demethylaconitine | [CYP2C9 protein results in increased metabolism of Aconitine] which results in increased chemical synthesis of 16-O-demethylaconitine | 21277363 |
| C033020 | 1-aminobenzotriazole | 1-aminobenzotriazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] | 15618748 |
| C029350 | 1-naphthol | CYP2C9 protein results in increased abundance of 1-naphthol | 16243959 |
| C024336 | 1-phenylazo-2-naphthol | CYP2C9 protein results in increased oxidation of 1-phenylazo-2-naphthol | 17159775 |
| C083998 | 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a | CYP2C9 protein results in increased abundance of 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a | 11668218 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [2-tert-butylhydroquinone results in increased expression of CYP2C9 mRNA] | 24830941 |
| C051450 | 2-ethyl-5-carboxypentyl phthalate | [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of 2-ethyl-5-carboxypentyl phthalate | 23545481 |
| C586542 | 2'-(glutathion-S-yl)-deschlorodiclofenac | [CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac | 24246759 |
| C005328 | 2-nitroanisole | CYP2C9 protein results in increased oxidation of 2-nitroanisole | 21218109 |
| C540904 | 2-oxo-clopidogrel | CYP2C9 protein results in increased oxidation of 2-oxo-clopidogrel | 19812348 |
| C540904 | 2-oxo-clopidogrel | Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased oxidation of 2-oxo-clopidogrel] | 19812348 |
| C045022 | 2-propyl-4-pentenoic acid | CYP2C9 protein results in increased chemical synthesis of 2-propyl-4-pentenoic acid | 16945988 |
| C018855 | 2-tert-butylhydroquinone | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [2-tert-butylhydroquinone results in increased expression of CYP2C9 mRNA] | 24830941 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [FOS protein binds to CYP2C9 promoter] | 24830941 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [JUND protein binds to CYP2C9 promoter] | 24830941 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone promotes the reaction [JUND protein modified form binds to CYP2C9 promoter] | 24830941 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of CYP2C9 mRNA | 24830941 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of CYP2C9 protein | 24830941 |
| C018855 | 2-tert-butylhydroquinone | JUND mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of CYP2C9 mRNA] | 24830941 |
| C018855 | 2-tert-butylhydroquinone | pyrazolanthrone inhibits the reaction [2-tert-butylhydroquinone results in increased expression of CYP2C9 mRNA] | 24830941 |
| C109602 | 3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate | "3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate results in decreased activity of CYP2C9 protein" | 16049129 |
| C109602 | 3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate | "CYP2C9 protein affects the metabolism of 3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate" | 16049129 |
| C509288 | 3',4'-dimethoxyflavone | "3',4'-dimethoxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]" | 21053930 |
| C041477 | 3-hydroxyflavone | 3-hydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| C008745 | 4,4'-bisphenol F | "CYP2C9 protein results in increased glutathionylation of 4,4'-bisphenol F" | 23470418 |
| C008745 | 4,4'-bisphenol F | "CYP2C9 protein results in increased glutathionylation of 4,4'-bisphenol F metabolite" | 23470418 |
| C008745 | 4,4'-bisphenol F | "CYP2C9 protein results in increased hydroxylation of 4,4'-bisphenol F" | 23470418 |
| C438583 | 4-((4-bromophenyl)-(ethoxyimino)methyl)-1'-((2,4-dimethyl-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine N-oxide | "CYP2C9 protein affects the metabolism of 4-((4-bromophenyl)-(ethoxyimino)methyl)-1'-((2,4-dimethyl-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine N-oxide" | 16012074 |
| C438583 | 4-((4-bromophenyl)-(ethoxyimino)methyl)-1'-((2,4-dimethyl-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine N-oxide | "CYP2C9 protein results in decreased ethylation of 4-((4-bromophenyl)-(ethoxyimino)methyl)-1'-((2,4-dimethyl-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine N-oxide" | 16012074 |
| C570106 | 4,4'-cyclohexylidenebisphenol | "CYP2C9 protein results in increased glutathionylation of 4,4'-cyclohexylidenebisphenol" | 23470418 |
| C570106 | 4,4'-cyclohexylidenebisphenol | "CYP2C9 protein results in increased glutathionylation of 4,4'-cyclohexylidenebisphenol metabolite" | 23470418 |
| C570106 | 4,4'-cyclohexylidenebisphenol | "CYP2C9 protein results in increased hydroxylation of 4,4'-cyclohexylidenebisphenol" | 23470418 |
| C583074 | 4,4'-hexafluorisopropylidene diphenol | "CYP2C9 protein results in increased hydroxylation of 4,4'-hexafluorisopropylidene diphenol" | 23470418 |
| C545880 | 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide | "CYP2C9 protein results in increased metabolism of and results in increased activity of 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide" | 19697924 |
| C545880 | 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide | "[CYP2C9 protein results in increased metabolism of and results in increased activity of 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide] which results in increased chemical synthesis of chlorophenyl isocyanate" | 19697924 |
| C545880 | 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide | "Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased metabolism of 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide]" | 19697924 |
| C012358 | 4-hydroxycyclophosphamide | CYP2C9 protein results in increased chemical synthesis of 4-hydroxycyclophosphamide | 24819615 |
| C108036 | 4'-hydroxydiclofenac | [CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 4'-hydroxydiclofenac | 24246759 |
| C108036 | 4'-hydroxydiclofenac | [[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac | 24246759 |
| C108036 | 4'-hydroxydiclofenac | CYP2C9 protein results in increased chemical synthesis of 4'-hydroxydiclofenac | 12401345|1515555 |
| C108036 | 4'-hydroxydiclofenac | [CYP2C9 protein results in increased metabolism of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac | 24104198 |
| C108036 | 4'-hydroxydiclofenac | [CYP2C9 protein results in increased metabolism of Diclofenac] which results in increased chemical synthesis of 4'-hydroxydiclofenac | 25084468 |
| C108036 | 4'-hydroxydiclofenac | Sulfaphenazole inhibits the reaction [[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 4'-hydroxydiclofenac] | 24246759 |
| C108036 | 4'-hydroxydiclofenac | CYP2C9 protein results in increased abundance of 4'-hydroxydiclofenac | 27130197 |
| C108036 | 4'-hydroxydiclofenac | CYP2C9 protein results in increased metabolism of 4'-hydroxydiclofenac | 27130197 |
| C108036 | 4'-hydroxydiclofenac | [CYP2C9 protein results in increased oxidation of Diclofenac] which results in increased chemical synthesis of 4'-hydroxydiclofenac | 24552538 |
| C055492 | 4-hydroxy-N-desmethyltamoxifen | 4-hydroxy-N-desmethyltamoxifen results in decreased activity of CYP2C9 protein | 29285606 |
| C019429 | 4-hydroxyretinoic acid | CYP2C9 protein results in increased chemical synthesis of 4-hydroxyretinoic acid | 10874126 |
| C091207 | 4-hydroxyvalproate | CYP2C9 protein results in increased chemical synthesis of 4-hydroxyvalproate | 16945988 |
| C059853 | 4'-hydroxywarfarin | 4'-hydroxywarfarin binds to and results in decreased activity of CYP2C9 protein | 20429590 |
| C059853 | 4'-hydroxywarfarin | [4'-hydroxywarfarin binds to and results in increased activity of NR1I2 protein] which results in increased expression of CYP2C9 mRNA | 20735727 |
| C059853 | 4'-hydroxywarfarin | 4'-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin] | 20429590 |
| C028690 | 4-isopropylphenol | CYP2C9 protein results in increased glutathionylation of 4-isopropylphenol | 23470418 |
| C487850 | 4'-methoxyflavone | 4'-methoxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| C023439 | 4-methylimidazole | 4-methylimidazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| C002202 | 4-oxoretinoic acid | CYP2C9 protein results in increased chemical synthesis of 4-oxoretinoic acid | 10874126 |
| C105260 | 4-tert-octylphenol | CYP2C9 gene SNP results in increased susceptibility to 4-tert-octylphenol | 23555028 |
| C040997 | 5-bromotryptamine | 5-bromotryptamine analog results in decreased activity of CYP2C9 protein | 26599973 |
| C040997 | 5-bromotryptamine | [5-bromotryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| C529169 | 5-chlorotryptamine | 5-chlorotryptamine analog results in decreased activity of CYP2C9 protein | 26599973 |
| C529169 | 5-chlorotryptamine | [5-chlorotryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| C051101 | 5-fluoro-alpha-methyltryptamine | 5-fluoro-alpha-methyltryptamine results in decreased activity of CYP2C9 protein | 26599973 |
| C051101 | 5-fluoro-alpha-methyltryptamine | [5-fluoro-alpha-methyltryptamine results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| C034536 | 5-fluorotryptamine | 5-fluorotryptamine analog results in decreased activity of CYP2C9 protein | 26599973 |
| C034536 | 5-fluorotryptamine | [5-fluorotryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| C062711 | 5-hydroxyflavone | 5-hydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| C041405 | 5-hydroxythienilic acid | CYP2C9 protein results in increased chemical synthesis of 5-hydroxythienilic acid | 22329513 |
| C091208 | 5-hydroxyvalproate | CYP2C9 protein results in increased chemical synthesis of 5-hydroxyvalproate | 16945988 |
| C487413 | 5-methoxyindole | 5-methoxyindole results in decreased activity of CYP2C9 protein | 18420780 |
| C027552 | 5-methyltryptamine | 5-methyltryptamine analog results in decreased activity of CYP2C9 protein | 26599973 |
| C027552 | 5-methyltryptamine | [5-methyltryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| C000588958 | 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid | 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid results in decreased activity of CYP2C9 protein | 23631744 |
| C547858 | 5-n-butyl-pyrazolo(1,5-a)pyrimidine | "5-n-butyl-pyrazolo(1,5-a)pyrimidine metabolite binds to CYP2C9 protein" | 19928966 |
| C475093 | 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime | "6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]" | 21768169 |
| C475093 | 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime | "6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2C9 mRNA" | 21768169 |
| C475093 | 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime | "Estradiol inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]]" | 21768169 |
| C475093 | 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime | "Estradiol inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2C9 mRNA]" | 21768169 |
| C475093 | 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime | "NR1I3 mutant form inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2C9 mRNA]" | 21768169 |
| C475093 | 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime | "NR1I3 mutant form inhibits the reaction [Estradiol inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2C9 mRNA]]" | 21768169 |
| C475093 | 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime | "NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2C9 mRNA]]" | 21768169 |
| C475093 | 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime | "[Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]]" | 21768169 |
| C475093 | 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime | "[Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2C9 mRNA]" | 21768169 |
| C475093 | 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime | "Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]]" | 21768169 |
| C475093 | 6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime | "Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2C9 mRNA]" | 21768169 |
| C485383 | 6,7-dihydroxyflavone | "6,7-dihydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]" | 21053930 |
| C008091 | 6-hydroxywarfarin | 6-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin] | 20429590 |
| C008091 | 6-hydroxywarfarin | 6-hydroxywarfarin results in decreased activity of CYP2C9 protein | 20429590 |
| C008091 | 6-hydroxywarfarin | 7-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 6-hydroxywarfarin] | 20429590 |
| C008091 | 6-hydroxywarfarin | [CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 6-hydroxywarfarin | 20429590 |
| C008091 | 6-hydroxywarfarin | [CYP2C9 protein results in increased metabolism of Warfarin] which results in increased chemical synthesis of 6-hydroxywarfarin | 19408964 |
| C107882 | 7,8-dihydromethysticin | "7,8-dihydromethysticin results in decreased activity of CYP2C9 protein" | 16033948 |
| C429845 | 7-hydroxyflavone | 7-hydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| C087837 | 7-hydroxywarfarin | 10-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin] | 20429590 |
| C087837 | 7-hydroxywarfarin | 4'-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin] | 20429590 |
| C087837 | 7-hydroxywarfarin | 6-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin] | 20429590 |
| C087837 | 7-hydroxywarfarin | 7-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 6-hydroxywarfarin] | 20429590 |
| C087837 | 7-hydroxywarfarin | 7-hydroxywarfarin results in decreased activity of CYP2C9 protein | 20429590 |
| C087837 | 7-hydroxywarfarin | 8-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin] | 20429590 |
| C087837 | 7-hydroxywarfarin | CYP2C9 gene polymorphism affects the abundance of 7-hydroxywarfarin | 25986145 |
| C087837 | 7-hydroxywarfarin | CYP2C9 protein results in increased chemical synthesis of 7-hydroxywarfarin | 25986145 |
| C087837 | 7-hydroxywarfarin | [CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin | 20429590 |
| C087837 | 7-hydroxywarfarin | [CYP2C9 protein results in increased metabolism of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin | 19408964 |
| C036696 | 7-methyltryptamine | 7-methyltryptamine analog results in decreased activity of CYP2C9 protein | 26599973 |
| C036696 | 7-methyltryptamine | [7-methyltryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| C050715 | 8,9-epoxyeicosatrienoic acid | "CYP2C9 protein results in increased chemical synthesis of 8,9-epoxyeicosatrienoic acid" | 12675279 |
| C050715 | 8,9-epoxyeicosatrienoic acid | "Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased chemical synthesis of 8,9-epoxyeicosatrienoic acid]" | 12675279 |
| C101436 | 8-hydroxywarfarin | 8-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin] | 20429590 |
| C101436 | 8-hydroxywarfarin | 8-hydroxywarfarin results in decreased activity of CYP2C9 protein | 20429590 |
| C023717 | acacetin | acacetin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| C042553 | acenaphthylene | CYP2C9 protein results in increased oxidation of acenaphthylene | 25642975 |
| D000074 | Acenocoumarol | CYP2C9 gene polymorphism affects the susceptibility to Acenocoumarol | 15213846|1686982 |
| D000074 | Acenocoumarol | CYP2C9 protein affects the metabolism of Acenocoumarol | 11918509 |
| D000074 | Acenocoumarol | CYP2C9 protein results in increased metabolism of Acenocoumarol | 16878445 |
| D000074 | Acenocoumarol | CYP2C9 protein results in increased susceptibility to Acenocoumarol | 16869821 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of CYP2C9 mRNA | 29067470 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of CYP2C9 mRNA | 22230336 |
| D000096 | Acetone | Acetone promotes the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] | 10611138 |
| C032159 | acetonitrile | acetonitrile promotes the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] | 10611138 |
| D000157 | Aconitine | [Amiodarone results in decreased activity of CYP2C9 protein] which results in decreased chemical synthesis of Aconitine metabolite | 21277363 |
| D000157 | Aconitine | CYP2C9 protein results in increased metabolism of Aconitine | 21277363 |
| D000157 | Aconitine | [CYP2C9 protein results in increased metabolism of Aconitine] which results in increased chemical synthesis of 16-O-demethylaconitine | 21277363 |
| C053001 | adefovir | adefovir results in decreased activity of CYP2C9 protein | 17162464 |
| C106812 | adefovir dipivoxil | adefovir dipivoxil results in decreased activity of CYP2C9 protein | 17162464 |
| C016601 | afimoxifene | CYP2C9 protein results in increased metabolism of afimoxifene | 29285606 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of CYP2C9 protein | 20106945 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of CYP2C9 mRNA | 27153756 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of CYP2C9 gene | 27153756 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of CYP2C9 mRNA | 21994236 |
| D016604 | Aflatoxin B1 | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Aflatoxin B1 | 23397584 |
| C090840 | alosetron | CYP2C9 affects the metabolism of alosetron | 11304902|1130490 |
| D017962 | alpha-Linolenic Acid | alpha-Linolenic Acid results in decreased activity of CYP2C9 protein | 16978661 |
| D017962 | alpha-Linolenic Acid | CYP2C9 protein results in increased metabolism of [alpha-Linolenic Acid co-treated with NADP] | 16978661 |
| C011512 | alpha-naphthoflavone | alpha-naphthoflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D000638 | Amiodarone | Amiodarone inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D000638 | Amiodarone | Amiodarone promotes the reaction [CYP2C9 protein affects the metabolism of Naproxen] | 16081671 |
| D000638 | Amiodarone | Amiodarone promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] | 14557374 |
| D000638 | Amiodarone | Amiodarone results in decreased activity of CYP2C9 protein | 16449812 |
| D000638 | Amiodarone | [Amiodarone results in decreased activity of CYP2C9 protein] which results in decreased chemical synthesis of 16-O-demethylaconitine | 21277363 |
| D000638 | Amiodarone | [Amiodarone results in decreased activity of CYP2C9 protein] which results in decreased chemical synthesis of Aconitine metabolite | 21277363 |
| D000638 | Amiodarone | CYP2C9 protein results in decreased susceptibility to Amiodarone | 26477383 |
| D000638 | Amiodarone | Amiodarone affects the reaction [CYP2C9 protein polymorphism results in decreased methylation of Naproxen] | 16815961 |
| D000639 | Amitriptyline | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Amitriptyline | 23397584 |
| D000655 | Amodiaquine | Amodiaquine results in decreased activity of CYP2C9 protein | 11124226 |
| D000894 | Anti-Inflammatory Agents, Non-Steroidal | "CYP2C9 gene polymorphism affects the susceptibility to Anti-Inflammatory Agents, Non-Steroidal" | 19715737 |
| D000894 | Anti-Inflammatory Agents, Non-Steroidal | "CYP2C9 protein results in increased metabolism of Anti-Inflammatory Agents, Non-Steroidal" | 19715737 |
| D000894 | Anti-Inflammatory Agents, Non-Steroidal | "Anti-Inflammatory Agents, Non-Steroidal results in increased expression of CYP2C9" | 19445531 |
| C030419 | andrographolide | andrographolide results in decreased expression of CYP2C9 mRNA | 19041297 |
| D000841 | Anisomycin | "[Anisomycin co-treated with 1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with NR1I3 protein] results in increased expression of CYP2C9 mRNA" | 23539296 |
| D000925 | Anticoagulants | CYP2C9 gene polymorphism affects the susceptibility to Anticoagulants | 19715737 |
| D047310 | Apigenin | Apigenin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| C004984 | apocarotenal | apocarotenal results in increased expression of CYP2C9 mRNA | 17034753 |
| D016718 | Arachidonic Acid | Arachidonic Acid results in decreased activity of CYP2C9 protein | 16978661 |
| D016718 | Arachidonic Acid | CYP2C9 protein results in increased metabolism of Arachidonic Acid | 12675279 |
| D016718 | Arachidonic Acid | CYP2C9 protein results in increased metabolism of [Arachidonic Acid co-treated with NADP] | 16978661 |
| D016718 | Arachidonic Acid | Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased metabolism of Arachidonic Acid] | 12675279 |
| D001140 | Aroclors | Aroclors results in increased expression of CYP2C9 protein | 29162470 |
| D001241 | Aspirin | CYP2C9 polymorphism affects the susceptibility to Aspirin | 21966608 |
| C423185 | avasimibe | avasimibe results in decreased activity of CYP2C9 protein | 15333513 |
| C423185 | avasimibe | avasimibe results in increased activity of and results in increased expression of CYP2C9 protein | 19202563 |
| C423185 | avasimibe | avasimibe results in increased expression of and results in increased activity of CYP2C9 protein | 15333513 |
| C006680 | baicalein | baicalein inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| C447119 | bazedoxifene | CYP2C9 protein results in increased glutathionylation of bazedoxifene | 22429462 |
| C096128 | benfuracarb | CYP2C9 protein results in increased oxidation of benfuracarb | 24016712 |
| C061004 | benidipine | benidipine results in decreased activity of CYP2C9 protein | 10805063|2773288 |
| D001553 | Benzbromarone | Benzbromarone analog binds to and results in decreased activity of CYP2C9 protein | 12814975|1517033 |
| D001553 | Benzbromarone | Benzbromarone binds to and results in decreased activity of CYP2C9 protein | 15170332 |
| D001553 | Benzbromarone | Benzbromarone binds to CYP2C9 protein | 12814975 |
| D001553 | Benzbromarone | Benzbromarone inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D001553 | Benzbromarone | Benzbromarone inhibits the reaction [CYP2C9 protein affects the metabolism of Warfarin] | 10613612 |
| D001553 | Benzbromarone | Benzbromarone inhibits the reaction [CYP2C9 protein polymorphism affects the hydroxylation of Flurbiprofen] | 15955872 |
| D001553 | Benzbromarone | Benzbromarone promotes the reaction [CYP2C9 protein affects the metabolism of Naproxen] | 16081671 |
| D001553 | Benzbromarone | Benzbromarone promotes the reaction [CYP2C9 protein polymorphism affects the hydroxylation of Flurbiprofen] | 15955872 |
| D001553 | Benzbromarone | CYP2C9 protein affects the metabolism of Benzbromarone | 18020424|2132106 |
| D001553 | Benzbromarone | Benzbromarone affects the reaction [CYP2C9 protein polymorphism results in decreased methylation of Naproxen] | 16815961 |
| D001553 | Benzbromarone | Benzbromarone analog affects the reaction [CYP2C9 protein polymorphism results in decreased methylation of Naproxen] | 16815961 |
| D001553 | Benzbromarone | Benzbromarone analog binds to and results in decreased activity of CYP2C9 protein | 18255300 |
| D001553 | Benzbromarone | CYP2C9 protein results in increased metabolism of Benzbromarone | 21449597 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in decreased expression of CYP2C9 mRNA | 16985168 |
| D003374 | Coumarins | Amiodarone promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] | 14557374 |
| D003374 | Coumarins | CYP2C9 protein results in increased metabolism of Coumarins | 14557374 |
| D003374 | Coumarins | Dichlorphenamide promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] | 14557374 |
| D003374 | Coumarins | estropipate promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] | 14557374 |
| D003374 | Coumarins | Niclosamide promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] | 14557374 |
| D003374 | Coumarins | Triiodothyronine promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] | 14557374 |
| D019207 | beta Carotene | beta Carotene results in increased expression of CYP2C9 mRNA | 17034753 |
| D004958 | Estradiol | [ESR1 protein co-treated with MED25 protein co-treated with Estradiol] results in increased activity of CYP2C9 protein | 27273787 |
| D004958 | Estradiol | [ESR1 protein co-treated with MED25 protein co-treated with Estradiol] results in increased expression of CYP2C9 mRNA | 27273787 |
| D004958 | Estradiol | "Estradiol inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]]" | 21768169 |
| D004958 | Estradiol | "Estradiol inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2C9 mRNA]" | 21768169 |
| D004958 | Estradiol | Estradiol inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA] | 21768169 |
| D004958 | Estradiol | Estradiol results in increased activity of CYP2C9 protein | 22837389 |
| D004958 | Estradiol | "NR1I3 mutant form inhibits the reaction [Estradiol inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2C9 mRNA]]" | 21768169 |
| D004958 | Estradiol | NR1I3 mutant form inhibits the reaction [Estradiol inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA]] | 21768169 |
| D004958 | Estradiol | "[Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]]" | 21768169 |
| D004958 | Estradiol | "[Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2C9 mRNA]" | 21768169 |
| D004958 | Estradiol | [Progesterone co-treated with Estradiol] inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA] | 21768169 |
| D001663 | Bilirubin | Bilirubin results in increased expression of CYP2C9 mRNA | 15382119 |
| D001663 | Bilirubin | IL1B protein inhibits the reaction [Bilirubin results in increased expression of CYP2C9 mRNA] | 15382119 |
| C004541 | biochanin A | biochanin A results in decreased activity of CYP2C9 protein | 26278343 |
| C543008 | bis(4-hydroxyphenyl)sulfone | CYP2C9 protein results in increased hydroxylation of bis(4-hydroxyphenyl)sulfone | 27213244 |
| C006780 | bisphenol A | bisphenol A results in increased expression of CYP2C9 mRNA | 26196221 |
| C006780 | bisphenol A | CYP2C9 protein results in increased glutathionylation of bisphenol A | 23470418 |
| C006780 | bisphenol A | CYP2C9 protein results in increased glutathionylation of bisphenol A metabolite | 23470418 |
| C006780 | bisphenol A | CYP2C9 protein results in increased hydroxylation of bisphenol A | 23470418 |
| C006780 | bisphenol A | CYP2C9 protein results in increased hydroxylation of bisphenol A metabolite | 23470418 |
| C006780 | bisphenol A | [ESR1 protein co-treated with MED25 protein co-treated with bisphenol A] results in increased activity of CYP2C9 protein | 27273787 |
| C006780 | bisphenol A | [ESR1 protein co-treated with MED25 protein co-treated with bisphenol A] results in increased expression of CYP2C9 mRNA | 27273787 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of CYP2C9 mRNA | 25181051 |
| D000069286 | Bortezomib | CYP2C9 protein affects the metabolism of Bortezomib | 15764713 |
| C086232 | bosentan | bosentan results in increased expression of CYP2C9 | 16550733 |
| C010831 | bufuralol | CYP2C9 protein results in increased hydroxylation of bufuralol | 9429232 |
| D002066 | Busulfan | [GSTM1 protein co-treated with CYP2C9 protein] results in increased susceptibility to [Busulfan co-treated with Cyclophosphamide] | 28744217 |
| C018475 | butyraldehyde | butyraldehyde results in increased expression of CYP2C9 mRNA | 26079696 |
| D002104 | Cadmium | Cadmium results in increased expression of CYP2C9 protein | 11551516 |
| D002110 | Caffeine | Caffeine results in decreased activity of CYP2C9 protein | 18420780 |
| D002185 | Cannabidiol | Cannabidiol results in decreased activity of CYP2C9 protein | 24667653 |
| D002211 | Capsaicin | Capsaicin results in decreased activity of CYP2C9 protein | 22375877 |
| D002220 | Carbamazepine | Carbamazepine results in increased activity of CYP2C9 protein | 19202563 |
| D002220 | Carbamazepine | Carbamazepine results in increased expression of CYP2C9 mRNA | 17112801 |
| D002220 | Carbamazepine | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Carbamazepine | 23397584 |
| D002220 | Carbamazepine | CYP2C9 protein affects the metabolism of Carbamazepine | 15286053 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased activity of CYP2C9 protein | 16288784 |
| D002251 | Carbon Tetrachloride | Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased activity of CYP2C9 protein] | 16288784 |
| D000068579 | Celecoxib | CYP2C9 protein results in increased metabolism of Celecoxib | 17681167|1908287 |
| C088453 | Celsior | Celsior results in decreased activity of CYP2C9 protein | 15448115 |
| C088453 | Celsior | Celsior results in decreased expression of CYP2C9 mRNA | 15448115 |
| C452229 | chlorophenyl isocyanate | "[CYP2C9 protein results in increased metabolism of and results in increased activity of 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide] which results in increased chemical synthesis of chlorophenyl isocyanate" | 19697924 |
| D002746 | Chlorpromazine | Chlorpromazine results in decreased activity of CYP2C9 protein | 15135088 |
| D002746 | Chlorpromazine | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Chlorpromazine | 23397584 |
| D002746 | Chlorpromazine | CYP2C9 protein results in decreased susceptibility to Chlorpromazine | 26477383 |
| D004390 | Chlorpyrifos | CYP2C9 protein affects the metabolism of Chlorpyrifos | 16190164 |
| D002784 | Cholesterol | Cholesterol results in decreased activity of CYP2C9 protein | 18420780 |
| D002793 | Cholic Acids | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CYP2C9 mRNA | 27344345 |
| C043561 | chrysin | chrysin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| C027113 | chrysophanic acid | chrysophanic acid results in decreased activity of CYP2C9 protein | 27633141 |
| D002927 | Cimetidine | Cimetidine results in decreased activity of CYP2C9 protein | 19909766 |
| D002927 | Cimetidine | styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP2C9 protein] | 19909766 |
| C029010 | cinnamic acid | cinnamic acid analog results in decreased activity of CYP2C9 protein | 15072549 |
| D020117 | Cisapride | Cisapride results in decreased activity of CYP2C9 protein | 15306208 |
| D002995 | Clofibric Acid | Clofibric Acid results in increased expression of CYP2C9 mRNA | 15802389 |
| C055162 | clopidogrel | CYP2C9 gene affects the reaction [CYP2C19 gene affects the susceptibility to clopidogrel] | 19926050|1993479 |
| C055162 | clopidogrel | CYP2C9 gene SNP affects the susceptibility to clopidogrel | 17900275 |
| C055162 | clopidogrel | CYP2C9 gene SNP results in decreased metabolism of clopidogrel | 17900275 |
| C055162 | clopidogrel | CYP2C9 protein results in increased oxidation of and results in increased cleavage of clopidogrel metabolite | 19170597 |
| D003022 | Clotrimazole | Clotrimazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D003022 | Clotrimazole | Clotrimazole results in increased activity of and results in increased expression of CYP2C9 protein | 19202563 |
| D003024 | Clozapine | [Clozapine results in decreased activity of CYP2C9 protein] which results in increased susceptibility to Phenytoin | 17961958 |
| D003024 | Clozapine | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Clozapine | 23397584 |
| D003024 | Clozapine | CYP2C9 protein results in increased metabolism of Clozapine | 18809730 |
| D003042 | Cocaine | Cocaine results in decreased expression of CYP2C9 mRNA | 16188404 |
| D003042 | Cocaine | Cocaine results in decreased expression of CYP2C9 protein | 16188404 |
| D009249 | NADP | CYP2C9 protein results in increased metabolism of [alpha-Linolenic Acid co-treated with NADP] | 16978661 |
| D009249 | NADP | CYP2C9 protein results in increased metabolism of [Arachidonic Acid co-treated with NADP] | 16978661 |
| D009249 | NADP | CYP2C9 protein results in increased metabolism of [Docosahexaenoic Acids co-treated with NADP] | 16978661 |
| D009249 | NADP | CYP2C9 protein results in increased metabolism of [Eicosapentaenoic Acid co-treated with NADP] | 16978661 |
| D009249 | NADP | CYP2C9 protein results in increased metabolism of [Linoleic Acid co-treated with NADP] | 16978661 |
| D009249 | NADP | Ketoconazole affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D009249 | NADP | [NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | 24120545 |
| D009249 | NADP | Quercetin inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D009249 | NADP | Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D009249 | NADP | Tranylcypromine affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D003300 | Copper | [CYP2C9 protein co-treated with Copper] results in increased activity of Eugenol | 15576237 |
| C030123 | coumarin | CYP2C9 protein polymorphism affects the metabolism of coumarin | 17849045 |
| C030123 | coumarin | CYP2C9 protein polymorphism affects the susceptibility to coumarin | 23582453 |
| C007164 | cumene hydroperoxide | CYP2C9 protein affects the oxidation of cumene hydroperoxide | 17478480 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased activity of CYP2C9 protein] | 16288784 |
| D003505 | Cyclodextrins | Cyclodextrins analog results in increased activity of CYP2C9 protein | 15665498 |
| D053138 | Cyclohexenes | Cyclohexenes analog inhibits the reaction [CYP2C9 protein results in increased metabolism of Diclofenac] | 20452209 |
| D003520 | Cyclophosphamide | CYP2C9 protein results in increased metabolism of Cyclophosphamide | 11377097|2481961 |
| D003520 | Cyclophosphamide | CYP2C9 protein results in increased susceptibility to Cyclophosphamide | 10991840 |
| D003520 | Cyclophosphamide | CYP2C9 results in increased activity of Cyclophosphamide | 9241661 |
| D003520 | Cyclophosphamide | [GSTM1 protein co-treated with CYP2C9 protein] results in increased susceptibility to [Busulfan co-treated with Cyclophosphamide] | 28744217 |
| D003520 | Cyclophosphamide | Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased susceptibility to Cyclophosphamide] | 10991840 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in decreased activity of CYP2C9 protein | 18420780 |
| D003520 | Cyclophosphamide | CYP2C9 affects the activity of Cyclophosphamide | 16475710 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of CYP2C9 mRNA | 20106945|2798913 |
| C017160 | cypermethrin | cypermethrin results in decreased activity of CYP2C9 protein | 18420780 |
| C017160 | cypermethrin | cypermethrin results in increased expression of CYP2C9 mRNA | 22310298 |
| C093628 | cyproconazole | cyproconazole results in decreased activity of CYP2C9 protein | 21251949 |
| C004742 | daidzein | daidzein results in decreased activity of CYP2C9 protein | 18420780 |
| D003622 | Dapsone | CYP2C9 protein affects the metabolism of Dapsone | 12920490 |
| D003622 | Dapsone | Dapsone promotes the reaction [CYP2C9 protein polymorphism results in decreased methylation of Naproxen] | 15130760 |
| D003622 | Dapsone | Dapsone promotes the reaction [CYP2C9 protein polymorphism results in increased hydroxylation of Flurbiprofen] | 15130760 |
| D003622 | Dapsone | Dapsone promotes the reaction [CYP2C9 protein results in decreased methylation of Naproxen] | 15130760 |
| D003622 | Dapsone | Dapsone promotes the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 15130760 |
| D003622 | Dapsone | Dapsone results in decreased activity of CYP2C9 protein | 11124226 |
| C017180 | decamethrin | decamethrin results in increased expression of CYP2C9 mRNA | 22310298 |
| D003671 | DEET | DEET results in increased expression of CYP2C9 mRNA | 27091632 |
| D003671 | DEET | [fipronil co-treated with DEET] results in increased expression of CYP2C9 mRNA | 27091632 |
| D020008 | Delavirdine | Delavirdine results in decreased activity of CYP2C9 protein | 11225565 |
| D013759 | Dronabinol | CYP2C9 polymorphism affects the susceptibility to Dronabinol | 19005461 |
| C036116 | desethylamiodarone | desethylamiodarone inhibits the reaction [CYP2C9 protein polymorphism results in decreased methylation of Naproxen] | 16815961 |
| C047386 | desethylamodiaquine | CYP2C9 protein results in increased metabolism of desethylamodiaquine | 28478157 |
| C047386 | desethylamodiaquine | desethylamodiaquine results in decreased activity of CYP2C9 protein | 11124226 |
| D003891 | Desipramine | Desipramine results in decreased activity of CYP2C9 protein | 15135088 |
| D003907 | Dexamethasone | Dexamethasone results in increased activity of CYP2C9 protein | 19202563 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of and results in increased activity of CYP2C9 protein | 15802389 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of CYP2C9 mRNA | 15802389 |
| D036381 | Diarylheptanoids | Diarylheptanoids results in decreased activity of CYP2C9 protein | 23850985 |
| D003976 | Diazinon | CYP2C9 protein results in increased metabolism of and results in increased activity of Diazinon | 11708902 |
| C018912 | dibenzoanthracene-3,4-dihydrodiol | "[CYP2C9 protein results in increased metabolism of 1,2,5,6-dibenzanthracene] which results in increased chemical synthesis of dibenzoanthracene-3,4-dihydrodiol" | 8638931 |
| C558664 | dibenzylfluorescein | CYP2C9 protein results in increased metabolism of dibenzylfluorescein | 23850985 |
| C558664 | dibenzylfluorescein | [CYP2C9 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein | 23850985 |
| C558664 | dibenzylfluorescein | Sulfaphenazole inhibits the reaction [[CYP2C9 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein] | 23850985 |
| D002945 | Cisplatin | CYP2C9 protein affects the susceptibility to Cisplatin | 16217747 |
| D004005 | Dichlorphenamide | Dichlorphenamide promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] | 14557374 |
| D004008 | Diclofenac | CYP2C9 protein affects the metabolism of Diclofenac | 15801540 |
| D004008 | Diclofenac | Diclofenac inhibits the reaction [CYP2C9 protein affects the hydroxylation of Tolbutamide] | 9004453 |
| D004008 | Diclofenac | 1-aminobenzotriazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] | 15618748 |
| D004008 | Diclofenac | 4-methylimidazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | [5-bromotryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| D004008 | Diclofenac | [5-chlorotryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| D004008 | Diclofenac | [5-fluoro-alpha-methyltryptamine results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| D004008 | Diclofenac | [5-fluorotryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| D004008 | Diclofenac | [5-methyltryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| D004008 | Diclofenac | [7-methyltryptamine analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| D004008 | Diclofenac | Amiodarone inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | Benzbromarone inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | Clotrimazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | Cyclohexenes analog inhibits the reaction [CYP2C9 protein results in increased metabolism of Diclofenac] | 20452209 |
| D004008 | Diclofenac | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Diclofenac | 23397584 |
| D004008 | Diclofenac | [CYP2C19 protein co-treated with CYP2C9 protein] results in increased hydroxylation of Diclofenac | 15486075 |
| D004008 | Diclofenac | CYP2C9 gene mutant form inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] | 25994031|2599403 |
| D004008 | Diclofenac | CYP2C9 gene polymorphism affects the hydrolysis of Diclofenac | 9698079 |
| D004008 | Diclofenac | CYP2C9 gene polymorphism results in decreased hydroxylation of Diclofenac | 11455026 |
| D004008 | Diclofenac | CYP2C9 protein affects the metabolism of Diclofenac | 15801540|1608167 |
| D004008 | Diclofenac | CYP2C9 protein binds to Diclofenac | 15039296 |
| D004008 | Diclofenac | [CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac | 24246759 |
| D004008 | Diclofenac | [[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac | 24246759 |
| D004008 | Diclofenac | [CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased metabolism of Diclofenac | 24246759 |
| D004008 | Diclofenac | CYP2C9 protein results in increased hydrolysis of Diclofenac | 9698079 |
| D004008 | Diclofenac | CYP2C9 protein results in increased hydroxylation of and results in increased susceptibility to Diclofenac | 28762043 |
| D004008 | Diclofenac | CYP2C9 protein results in increased hydroxylation of Diclofenac | 10975605|1099184 |
| D004008 | Diclofenac | CYP2C9 protein results in increased metabolism of Diclofenac | 12401345|1246424 |
| D004008 | Diclofenac | [CYP2C9 protein results in increased metabolism of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac | 24104198 |
| D004008 | Diclofenac | [CYP2C9 protein results in increased metabolism of Diclofenac] which results in increased chemical synthesis of 4'-hydroxydiclofenac | 25084468 |
| D004008 | Diclofenac | CYP2C9 protein results in increased oxidation of Diclofenac | 17478480 |
| D004008 | Diclofenac | [CYP3A4 protein co-treated with CYP2C9 protein co-treated with UGT2B7 protein] results in increased susceptibility to Diclofenac | 28762043 |
| D004008 | Diclofenac | [CYP3A4 protein co-treated with CYP2C9 protein] results in increased susceptibility to Diclofenac | 28762043 |
| D004008 | Diclofenac | Diclofenac results in decreased activity of CYP2C9 protein | 15135088 |
| D004008 | Diclofenac | Diclofenac results in increased activity of CYP2C9 protein | 15802386 |
| D004008 | Diclofenac | Fluconazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | [Fluconazole results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| D004008 | Diclofenac | fluvastatin inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | Ibuprofen inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | Ketoconazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | Lansoprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] | 15258107 |
| D004008 | Diclofenac | Miconazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | Omeprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] | 15258107 |
| D004008 | Diclofenac | pantoprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] | 15258107 |
| D004008 | Diclofenac | perfluorooctane sulfonic acid inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] | 21964418 |
| D004008 | Diclofenac | Piroxicam inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | Quinine inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | rabeprazole-thioether inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] | 15258107 |
| D004008 | Diclofenac | Sertraline inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | sitaxsentan inhibits the reaction [CYP2C9 protein results in increased metabolism of Diclofenac] | 23721565 |
| D004008 | Diclofenac | Sulfaphenazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased metabolism of Diclofenac] | 12569440|2811916 |
| D004008 | Diclofenac | [Sulfaphenazole results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 22447115|2659997 |
| D004008 | Diclofenac | Sulfinpyrazone inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | Ticrynafen inhibits the reaction [CYP2C9 protein results in increased metabolism of Diclofenac] | 16049126 |
| D004008 | Diclofenac | Tolbutamide inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | [Tryptamines analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| D004008 | Diclofenac | Warfarin inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | zafirlukast inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D004008 | Diclofenac | Diclofenac results in decreased activity of CYP2C9 protein | 18420780 |
| D004008 | Diclofenac | CYP2C9 protein affects the metabolism of Diclofenac | 15801540 |
| D004008 | Diclofenac | CYP2C9 protein affects the hydroxylation of Diclofenac | 15044613 |
| D004008 | Diclofenac | CYP2C9 protein results in increased oxidation of Diclofenac | 24552538 |
| D004008 | Diclofenac | [CYP2C9 protein results in increased oxidation of Diclofenac] which results in increased chemical synthesis of 4'-hydroxydiclofenac | 24552538 |
| C121718 | dicyclanil | dicyclanil results in increased expression of CYP2C9 mRNA | 15664270 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of CYP2C9 mRNA | 21852083 |
| C012906 | dihydrocapsaicin | dihydrocapsaicin results in decreased activity of CYP2C9 protein | 22375877 |
| D004087 | Dihydroergotamine | Dihydroergotamine results in decreased activity of CYP2C9 protein | 18420780 |
| C012621 | dimemorfan | CYP2C9 protein results in increased oxidation of dimemorfan | 19593786 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "CYP2C9 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene" | 20507880 |
| C039602 | diosmetin | diosmetin results in decreased activity of CYP2C9 protein | 28867436 |
| D004281 | Docosahexaenoic Acids | CYP2C9 protein results in increased metabolism of [Docosahexaenoic Acids co-treated with NADP] | 16978661 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in decreased activity of CYP2C9 protein | 16978661 |
| D004298 | Dopamine | Dopamine results in decreased activity of CYP2C9 protein | 18420780 |
| D004365 | Drugs, Chinese Herbal | "[Drugs, Chinese Herbal results in increased activity of NR1I2 protein] which results in increased expression of CYP2C9 mRNA" | 16267138 |
| C098320 | efavirenz | efavirenz results in decreased activity of CYP2C9 protein | 11225565 |
| D015118 | Eicosapentaenoic Acid | CYP2C9 protein results in increased metabolism of [Eicosapentaenoic Acid co-treated with NADP] | 16978661 |
| D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid results in decreased activity of CYP2C9 protein | 16978661 |
| C034192 | ellipticine | CYP2C9 protein mutant form results in increased metabolism of ellipticine | 22917556 |
| D004642 | Emodin | Emodin results in decreased activity of CYP2C9 protein | 27633141 |
| D004917 | Erythromycin | Erythromycin results in decreased activity of CYP2C9 protein | 18420780 |
| C009927 | estropipate | estropipate promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] | 14557374 |
| D004997 | Ethinyl Estradiol | CYP2C9 protein results in increased hydroxylation of Ethinyl Estradiol | 15304426 |
| D005054 | Eugenol | [CYP2C9 protein co-treated with Copper] results in increased activity of Eugenol | 15576237 |
| D015736 | Felodipine | Felodipine results in decreased activity of CYP2C9 protein | 27732883 |
| D005278 | Fenitrothion | Fenitrothion inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] | 22634058 |
| D005278 | Fenitrothion | Fenitrothion results in decreased activity of CYP2C9 protein | 20183062|2263405 |
| C017690 | fenvalerate | fenvalerate results in increased expression of CYP2C9 mRNA | 22310298 |
| C082360 | fipronil | [fipronil co-treated with DEET] results in increased expression of CYP2C9 mRNA | 27091632 |
| C082360 | fipronil | fipronil results in increased expression of CYP2C9 mRNA | 27091632 |
| C028610 | flavanone | flavanone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| C043562 | flavone | flavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D015725 | Fluconazole | Fluconazole affects the reaction [CYP2C9 gene polymorphism affects the metabolism of Flurbiprofen] | 18378563 |
| D015725 | Fluconazole | Fluconazole binds to and results in decreased activity of CYP2C9 protein | 28887089 |
| D015725 | Fluconazole | Fluconazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D015725 | Fluconazole | Fluconazole results in decreased activity of CYP2C9 protein | 15328084|1584349 |
| D015725 | Fluconazole | [Fluconazole results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| D015725 | Fluconazole | Fluconazole results in decreased activity of CYP2C9 protein | 16556082|1758025 |
| D019793 | Fluorescein | [CYP2C9 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein | 23850985 |
| D019793 | Fluorescein | Sulfaphenazole inhibits the reaction [[CYP2C9 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein] | 23850985 |
| D005473 | Fluoxetine | CYP2C9 gene polymorphism affects the abundance of Fluoxetine | 14726986 |
| D005473 | Fluoxetine | CYP2C9 protein affects the abundance of Fluoxetine | 15094477 |
| D005473 | Fluoxetine | CYP2C9 protein results in increased metabolism of Fluoxetine | 14726986 |
| D005473 | Fluoxetine | CYP2C9 affects the metabolism of Fluoxetine | 11304903 |
| D005473 | Fluoxetine | [CYP2C9 affects the metabolism of Fluoxetine] which results in increased chemical synthesis of norfluoxetine | 11304903 |
| D005476 | Fluphenazine | Fluphenazine results in decreased activity of CYP2C9 protein | 15135088 |
| D005480 | Flurbiprofen | Flurbiprofen inhibits the reaction [CYP2C9 protein affects the hydroxylation of Tolbutamide] | 9004453 |
| D005480 | Flurbiprofen | "3',4'-dimethoxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]" | 21053930 |
| D005480 | Flurbiprofen | 3-hydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | 4'-methoxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | 5-hydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | "6,7-dihydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen]" | 21053930 |
| D005480 | Flurbiprofen | 7-hydroxyflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | acacetin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | alpha-naphthoflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | Apigenin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | baicalein inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | Benzbromarone inhibits the reaction [CYP2C9 protein polymorphism affects the hydroxylation of Flurbiprofen] | 15955872 |
| D005480 | Flurbiprofen | Benzbromarone promotes the reaction [CYP2C9 protein polymorphism affects the hydroxylation of Flurbiprofen] | 15955872 |
| D005480 | Flurbiprofen | beta-Naphthoflavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | chrysin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | CYP2C9 gene polymorphism affects the hydrolysis of Flurbiprofen | 9698079 |
| D005480 | Flurbiprofen | CYP2C9 gene polymorphism affects the metabolism of Flurbiprofen | 11901091|1837856 |
| D005480 | Flurbiprofen | CYP2C9 protein affects the hydroxylation of Flurbiprofen | 15955872 |
| D005480 | Flurbiprofen | CYP2C9 protein polymorphism results in increased hydroxylation of Flurbiprofen | 15130760 |
| D005480 | Flurbiprofen | CYP2C9 protein results in increased hydrolysis of Flurbiprofen | 9698079 |
| D005480 | Flurbiprofen | CYP2C9 protein results in increased hydroxylation of Flurbiprofen | 15130760|2105393 |
| D005480 | Flurbiprofen | CYP2C9 protein results in increased metabolism of Flurbiprofen | 11901091|1837856 |
| D005480 | Flurbiprofen | Dapsone promotes the reaction [CYP2C9 protein polymorphism results in increased hydroxylation of Flurbiprofen] | 15130760 |
| D005480 | Flurbiprofen | Dapsone promotes the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 15130760 |
| D005480 | Flurbiprofen | flavanone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | flavone inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | Fluconazole affects the reaction [CYP2C9 gene polymorphism affects the metabolism of Flurbiprofen] | 18378563 |
| D005480 | Flurbiprofen | Flurbiprofen binds to CYP2C9 protein | 21053930 |
| D005480 | Flurbiprofen | galangin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | Genistein inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | kaempferol inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | naringenin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | naringin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005480 | Flurbiprofen | Quercetin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D005485 | Flutamide | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Flutamide | 23397584 |
| D005485 | Flutamide | Flutamide results in increased expression of CYP2C9 mRNA | 24793618 |
| C065180 | fluvastatin | fluvastatin inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| C065180 | fluvastatin | fluvastatin results in decreased activity of CYP2C9 protein | 10197301 |
| C037032 | galangin | galangin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D015248 | Gemfibrozil | Gemfibrozil results in decreased activity of CYP2C9 protein | 16042675 |
| D019833 | Genistein | Genistein inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| C048393 | germacrone | germacrone results in decreased activity of CYP2C9 protein | 23850985 |
| C063170 | Ginkgo biloba extract | Ginkgo biloba extract results in decreased activity of CYP2C9 protein | 15147983 |
| D005913 | Glipizide | CYP2C9 gene polymorphism results in decreased metabolism of Glipizide | 10208645 |
| D005913 | Glipizide | CYP2C9 protein results in increased metabolism of Glipizide | 10208645 |
| D005978 | Glutathione | [CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac | 24246759 |
| D005978 | Glutathione | [CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 4'-hydroxydiclofenac | 24246759 |
| D005978 | Glutathione | [CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac | 24246759 |
| D005978 | Glutathione | [[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased hydroxylation of Diclofenac] which results in increased abundance of 4'-hydroxydiclofenac | 24246759 |
| D005978 | Glutathione | [CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased metabolism of Diclofenac | 24246759 |
| D005978 | Glutathione | Sulfaphenazole inhibits the reaction [[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 4'-hydroxydiclofenac] | 24246759 |
| C010974 | glyphosate | glyphosate results in decreased activity of CYP2C9 protein | 20183062 |
| D006861 | Hydrogen Peroxide | CYP2C9 protein results in increased abundance of Hydrogen Peroxide | 25061110 |
| C031014 | hydroxymethyltolbutamide | CYP2C9 protein results in increased chemical synthesis of hydroxymethyltolbutamide | 15155557 |
| C001654 | hyperforin | hyperforin results in increased expression of and results in increased activity of CYP2C9 protein | 15100173 |
| C001654 | hyperforin | hyperforin results in increased expression of CYP2C9 mRNA | 14600250|1510017 |
| C001654 | hyperforin | NR1I2 protein affects the reaction [hyperforin results in increased expression of CYP2C9 mRNA] | 14600250 |
| D007052 | Ibuprofen | CYP2C9 gene polymorphism results in decreased metabolism of Ibuprofen | 15289789|1869483 |
| D007052 | Ibuprofen | CYP2C9 protein affects the susceptibility to Ibuprofen | 25578229 |
| D007052 | Ibuprofen | CYP2C9 protein binds to Ibuprofen | 15039296 |
| D007052 | Ibuprofen | CYP2C9 protein polymorphism affects the metabolism of Ibuprofen | 12152005 |
| D007052 | Ibuprofen | CYP2C9 protein results in increased metabolism of Ibuprofen | 12464242|1768116 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D007069 | Ifosfamide | CYP2C9 protein results in increased susceptibility to Ifosfamide | 20507880 |
| D007069 | Ifosfamide | CYP2C9 results in increased activity of Ifosfamide | 9241661 |
| D007069 | Ifosfamide | CYP2C9 affects the activity of Ifosfamide | 16475710 |
| C081309 | irbesartan | CYP2C9 gene polymorphism results in decreased susceptibility to irbesartan | 12359989 |
| C081309 | irbesartan | CYP2C9 protein results in increased metabolism of irbesartan | 12359989 |
| C051890 | irinotecan | irinotecan metabolite results in decreased activity of CYP2C9 protein | 11901092 |
| C549713 | isocarbophos | CYP2C9 protein results in increased metabolism of and results in decreased sulfation of and affects the activity of isocarbophos | 24752505 |
| C028904 | isoproturon | isoproturon results in decreased activity of CYP2C9 protein | 18420780 |
| D017275 | Isradipine | Isradipine results in decreased activity of CYP2C9 protein | 27732883 |
| D017964 | Itraconazole | Itraconazole results in decreased activity of CYP2C9 protein | 16556082 |
| D007559 | Ivermectin | Ivermectin results in decreased activity of CYP2C9 protein | 18420780 |
| C006552 | kaempferol | kaempferol inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D007654 | Ketoconazole | Ketoconazole affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D007654 | Ketoconazole | Ketoconazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D007654 | Ketoconazole | Ketoconazole inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA] | 16608920 |
| D007654 | Ketoconazole | Ketoconazole inhibits the reaction [Rifampin results in increased expression of CYP2C9 mRNA] | 16608920 |
| D007654 | Ketoconazole | Ketoconazole results in decreased activity of CYP2C9 protein | 14709627|1561874 |
| D007654 | Ketoconazole | Ketoconazole results in decreased expression of CYP2C9 mRNA | 16608920 |
| D007654 | Ketoconazole | Ketoconazole results in decreased activity of CYP2C9 protein | 18420780 |
| D007654 | Ketoconazole | Ketoconazole results in decreased activity of CYP2C9 protein | 16556082 |
| D007660 | Ketoprofen | Ketoprofen inhibits the reaction [CYP2C9 protein affects the hydroxylation of Tolbutamide] | 9004453 |
| D064747 | Lansoprazole | CYP2C9 protein results in increased hydroxylation of Lansoprazole | 12975331|8627562 |
| D064747 | Lansoprazole | Lansoprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] | 15258107 |
| C030358 | lauric acid | CYP2C9 gene polymorphism results in decreased hydroxylation of lauric acid | 11455026 |
| C030358 | lauric acid | CYP2C9 protein results in increased hydroxylation of lauric acid | 11455026|9241660 |
| D007854 | Lead | Lead results in decreased expression of CYP2C9 mRNA | 19921347 |
| C070840 | licochalcone A | licochalcone A results in decreased activity of CYP2C9 protein | 26100226 |
| D008095 | Lithocholic Acid | Lithocholic Acid results in decreased activity of CYP2C9 protein | 18420780 |
| D019808 | Losartan | CYP2C9 gene mutant form inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Losartan] | 25994031|2599403 |
| D019808 | Losartan | CYP2C9 protein affects the metabolism of Losartan | 20405111|2132106 |
| D019808 | Losartan | CYP2C9 protein results in increased hydroxylation of Losartan | 25994031 |
| D019808 | Losartan | CYP2C9 protein results in increased metabolism of Losartan | 19082874|1971573 |
| D019808 | Losartan | resveratrol inhibits the reaction [CYP2C9 protein results in increased metabolism of Losartan] | 20716633 |
| D019808 | Losartan | CYP2C9 protein results in increased metabolism of Losartan | 10197301 |
| D008294 | Malathion | Malathion inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] | 22634058 |
| D008294 | Malathion | Malathion results in decreased activity of CYP2C9 protein | 20183062|2263405 |
| C501277 | Mangifera indica extract | Mangifera indica extract results in decreased activity of CYP2C9 protein | 22815239 |
| C013592 | mangiferin | mangiferin results in decreased activity of CYP2C9 protein | 22815239 |
| C054218 | manidipine | manidipine results in decreased activity of CYP2C9 protein | 10805063 |
| D008528 | Mefenamic Acid | CYP2C9 protein results in increased glutathionylation of Mefenamic Acid analog | 25372302 |
| D008528 | Mefenamic Acid | CYP2C9 protein results in increased hydroxylation of Mefenamic Acid | 25372302 |
| D008528 | Mefenamic Acid | CYP2C9 protein results in increased metabolism of Mefenamic Acid | 12464242 |
| D008549 | Melarsoprol | Melarsoprol results in decreased activity of CYP2C9 protein | 11124226 |
| D008610 | Menthol | Menthol results in increased expression of CYP2C9 mRNA | 24594507 |
| D008617 | Mephenytoin | CYP2C9 protein affects the metabolism of Mephenytoin | 16648389 |
| D008617 | Mephenytoin | CYP2C9 protein results in increased hydrolysis of Mephenytoin | 21347438 |
| D008617 | Mephenytoin | Mephenytoin results in decreased activity of CYP2C9 protein | 18420780 |
| C050699 | mepirodipine | mepirodipine results in decreased activity of CYP2C9 protein | 10805063 |
| D003915 | Dextromethorphan | Dextromethorphan results in decreased activity of CYP2C9 protein | 18420780 |
| D008727 | Methotrexate | Methotrexate results in decreased expression of CYP2C9 mRNA | 24449571 |
| D008731 | Methoxychlor | [CYP2C19 protein co-treated with CYP2C9 protein] results in decreased methylation of Methoxychlor | 15486075 |
| D008731 | Methoxychlor | CYP2C9 protein results in decreased methylation of Methoxychlor | 12167570|9733665 |
| D008731 | Methoxychlor | Methoxychlor results in decreased activity of CYP2C9 protein | 18420780 |
| D008731 | Methoxychlor | CYP2C9 protein results in increased metabolism of Methoxychlor | 18585438 |
| D008730 | Methoxsalen | Methoxsalen results in decreased activity of CYP2C9 protein | 18420780 |
| C076881 | methysticin | methysticin results in decreased activity of CYP2C9 protein | 16033948 |
| D008795 | Metronidazole | Metronidazole results in decreased activity of CYP2C9 protein | 15869686 |
| D008825 | Miconazole | Miconazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D008825 | Miconazole | Miconazole results in decreased activity of CYP2C9 protein | 15328084 |
| D008874 | Midazolam | Midazolam results in decreased activity of CYP2C9 protein | 18420780 |
| C518174 | MK-0524 | CYP2C9 protein results in increased metabolism of MK-0524 | 17132765 |
| C479069 | mono(2-ethyl-5-hydroxyhexyl) phthalate | [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate | 23545481 |
| C479069 | mono(2-ethyl-5-hydroxyhexyl) phthalate | [CYP2C9 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate | 22186153 |
| C080276 | mono(2-ethyl-5-oxohexyl)phthalate | [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate | 23545481 |
| C080276 | mono(2-ethyl-5-oxohexyl)phthalate | [CYP2C9 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate | 22186153 |
| C016599 | mono-(2-ethylhexyl)phthalate | CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate | 23545481 |
| C016599 | mono-(2-ethylhexyl)phthalate | [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of 2-ethyl-5-carboxypentyl phthalate | 23545481 |
| C016599 | mono-(2-ethylhexyl)phthalate | [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate | 23545481 |
| C016599 | mono-(2-ethylhexyl)phthalate | [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate | 23545481 |
| C016599 | mono-(2-ethylhexyl)phthalate | [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of phthalic acid | 23545481 |
| C016599 | mono-(2-ethylhexyl)phthalate | CYP2C9 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate | 22186153 |
| C016599 | mono-(2-ethylhexyl)phthalate | [CYP2C9 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate | 22186153 |
| C016599 | mono-(2-ethylhexyl)phthalate | [CYP2C9 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate | 22186153 |
| C050132 | mono-N-demethyladinazolam | CYP2C9 protein results in decreased methylation of mono-N-demethyladinazolam | 9600717 |
| C437683 | motexafin gadolinium | motexafin gadolinium results in decreased activity of CYP2C9 protein | 17018578 |
| C031721 | naphthalene | naphthalene results in increased expression of CYP2C9 mRNA | 20500019 |
| D015058 | 1-Naphthylisothiocyanate | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CYP2C9 mRNA | 27344345 |
| D009288 | Naproxen | Amiodarone promotes the reaction [CYP2C9 protein affects the metabolism of Naproxen] | 16081671 |
| D009288 | Naproxen | Benzbromarone promotes the reaction [CYP2C9 protein affects the metabolism of Naproxen] | 16081671 |
| D009288 | Naproxen | CYP2C9 gene polymorphism affects the metabolism of Naproxen | 11901091 |
| D009288 | Naproxen | CYP2C9 protein affects the metabolism of Naproxen | 16081671 |
| D009288 | Naproxen | CYP2C9 protein polymorphism results in decreased methylation of Naproxen | 15130760 |
| D009288 | Naproxen | CYP2C9 protein results in decreased methylation of Naproxen | 15130760 |
| D009288 | Naproxen | CYP2C9 protein results in increased metabolism of Naproxen | 11901091|1246424 |
| D009288 | Naproxen | Dapsone promotes the reaction [CYP2C9 protein polymorphism results in decreased methylation of Naproxen] | 15130760 |
| D009288 | Naproxen | Dapsone promotes the reaction [CYP2C9 protein results in decreased methylation of Naproxen] | 15130760 |
| D009288 | Naproxen | Amiodarone affects the reaction [CYP2C9 protein polymorphism results in decreased methylation of Naproxen] | 16815961 |
| D009288 | Naproxen | Benzbromarone affects the reaction [CYP2C9 protein polymorphism results in decreased methylation of Naproxen] | 16815961 |
| D009288 | Naproxen | Benzbromarone analog affects the reaction [CYP2C9 protein polymorphism results in decreased methylation of Naproxen] | 16815961 |
| D009288 | Naproxen | CYP2C9 protein alternative form results in decreased methylation of Naproxen | 16815961 |
| D009288 | Naproxen | desethylamiodarone inhibits the reaction [CYP2C9 protein polymorphism results in decreased methylation of Naproxen] | 16815961 |
| C005273 | naringenin | naringenin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| C005274 | naringin | naringin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| C060142 | nateglinide | CYP2C9 protein affects the metabolism of nateglinide | 18159128 |
| C060142 | nateglinide | CYP2C9 protein affects the metabolism of nateglinide | 16042675 |
| D009529 | Nicardipine | Nicardipine results in decreased activity of CYP2C9 protein | 10805063|1586389 |
| D009534 | Niclosamide | Niclosamide promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] | 14557374 |
| D009534 | Niclosamide | Niclosamide results in increased activity of CYP2C9 protein | 11124226 |
| D009543 | Nifedipine | Nifedipine results in decreased activity of CYP2C9 protein | 18420780 |
| C012655 | nimesulide | CYP2C9 protein results in increased glutathionylation of nimesulide | 26524229 |
| C574385 | N,N-didesmethyl-4-hydroxytamoxifen | "CYP2C9 protein results in increased metabolism of N,N-didesmethyl-4-hydroxytamoxifen" | 29285606 |
| C574385 | N,N-didesmethyl-4-hydroxytamoxifen | "[CYP2C9 protein results in increased metabolism of N,N-didesmethyl-4-hydroxytamoxifen] which results in increased abundance of N,N-didesmethyl-4-hydroxytamoxifen" | 29285606 |
| C574385 | N,N-didesmethyl-4-hydroxytamoxifen | "N,N-didesmethyl-4-hydroxytamoxifen results in decreased activity of CYP2C9 protein" | 29285606 |
| C058272 | norclozapine | CYP2C9 protein results in increased chemical synthesis of norclozapine | 18809730 |
| C036139 | norfluoxetine | [CYP2C9 affects the metabolism of Fluoxetine] which results in increased chemical synthesis of norfluoxetine | 11304903 |
| C464660 | obeticholic acid | obeticholic acid results in decreased expression of CYP2C9 mRNA | 27939613 |
| C025589 | ochratoxin A | CYP2C9 protein results in increased susceptibility to ochratoxin A | 21781659|8542584 |
| C025589 | ochratoxin A | ochratoxin A results in increased expression of CYP2C9 mRNA | 21834667 |
| D019787 | Linoleic Acid | CYP2C9 protein results in increased metabolism of [Linoleic Acid co-treated with NADP] | 16978661 |
| D019787 | Linoleic Acid | Linoleic Acid results in decreased activity of CYP2C9 protein | 16978661 |
| D009853 | Omeprazole | Omeprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] | 15258107 |
| D009853 | Omeprazole | Omeprazole results in decreased activity of CYP2C9 protein | 18420780 |
| D062367 | ortho-Aminobenzoates | ortho-Aminobenzoates analog results in decreased activity of CYP2C9 protein | 17994679 |
| D062367 | ortho-Aminobenzoates | ortho-Aminobenzoates results in decreased activity of CYP2C9 protein | 18477506 |
| D010098 | Oxycodone | Oxycodone results in decreased expression of CYP2C9 mRNA | 23439660 |
| D010100 | Oxygen | Oxygen deficiency results in decreased expression of CYP2C9 mRNA | 19695866 |
| D017239 | Paclitaxel | Paclitaxel results in decreased activity of CYP2C9 protein | 19909766 |
| D017239 | Paclitaxel | Paclitaxel results in increased activity of CYP2C9 protein | 19202563 |
| C064276 | pantoprazole | pantoprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] | 15258107 |
| D010278 | Parathion | CYP2C9 protein affects the metabolism of Parathion | 17079358 |
| D010278 | Parathion | Parathion results in increased expression of CYP2C9 mRNA | 26196221 |
| D010419 | Pentamidine | Pentamidine results in decreased activity of CYP2C9 protein | 11124226 |
| D010464 | Perazine | CYP2C9 gene polymorphism affects the metabolism of Perazine | 11026737 |
| D010464 | Perazine | CYP2C9 protein results in decreased methylation of Perazine | 11026737 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] | 21964418 |
| C569762 | PF 03715455 | PF 03715455 results in decreased activity of CYP2C9 protein | 21888439 |
| D010622 | Phencyclidine | CYP2C9 protein affects the metabolism of Phencyclidine | 16782764 |
| D010634 | Phenobarbital | CYP2C9 gene polymorphism affects the metabolism of Phenobarbital | 17304159 |
| D010634 | Phenobarbital | Estradiol inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA] | 21768169 |
| D010634 | Phenobarbital | Ketoconazole inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA] | 16608920 |
| D010634 | Phenobarbital | NR1I3 mutant form inhibits the reaction [Estradiol inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA]] | 21768169 |
| D010634 | Phenobarbital | NR1I3 mutant form inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA] | 21768169 |
| D010634 | Phenobarbital | NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA]] | 21768169 |
| D010634 | Phenobarbital | Phenobarbital results in decreased activity of CYP2C9 protein | 19909766 |
| D010634 | Phenobarbital | Phenobarbital results in increased activity of and results in increased expression of CYP2C9 protein | 19202563 |
| D010634 | Phenobarbital | Phenobarbital results in increased activity of CYP2C9 mRNA | 19202563 |
| D010634 | Phenobarbital | Phenobarbital results in increased activity of CYP2C9 protein | 19328226 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of and results in increased activity of CYP2C9 protein | 15802389 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of CYP2C9 mRNA | 15629111|1580238 |
| D010634 | Phenobarbital | [Progesterone co-treated with Estradiol] inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA] | 21768169 |
| D010634 | Phenobarbital | Progesterone inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA] | 21768169 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of CYP2C9 | 19445531 |
| C033457 | phenobarbital quinidine | IL1B protein inhibits the reaction [phenobarbital quinidine results in increased expression of CYP2C9 mRNA] | 15382119 |
| C033457 | phenobarbital quinidine | phenobarbital quinidine results in increased expression of CYP2C9 mRNA | 15382119 |
| D010644 | Phenprocoumon | CYP2C9 gene polymorphism affects the susceptibility to Phenprocoumon | 18698879 |
| D010644 | Phenprocoumon | CYP2C9 protein results in increased metabolism of Phenprocoumon | 19082874 |
| C008838 | phenthoate | phenthoate inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] | 22634058 |
| C008838 | phenthoate | phenthoate results in decreased activity of CYP2C9 protein | 22634058 |
| D010653 | Phenylbutazone | Phenylbutazone inhibits the reaction [CYP2C9 protein affects the hydroxylation of Tolbutamide] | 9004453 |
| D010672 | Phenytoin | [Clozapine results in decreased activity of CYP2C9 protein] which results in increased susceptibility to Phenytoin | 17961958 |
| D010672 | Phenytoin | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Phenytoin | 23397584 |
| D010672 | Phenytoin | CYP2C9 5' UTR polymorphism results in decreased metabolism of Phenytoin | 11503012 |
| D010672 | Phenytoin | CYP2C9 gene polymorphism results in decreased hydroxylation of Phenytoin | 16873909|9860067 |
| D010672 | Phenytoin | CYP2C9 gene polymorphism results in decreased metabolism of Phenytoin | 10208645|1143450 |
| D010672 | Phenytoin | CYP2C9 gene polymorphism results in increased susceptibility to Phenytoin | 11740344 |
| D010672 | Phenytoin | CYP2C9 protein affects the metabolism of Phenytoin | 15855726|2040511 |
| D010672 | Phenytoin | CYP2C9 protein alternative form affects the metabolism of Phenytoin | 27163851 |
| D010672 | Phenytoin | CYP2C9 protein results in increased hydroxylation of Phenytoin | 16873909|2025243 |
| D010672 | Phenytoin | CYP2C9 protein results in increased metabolism of Phenytoin | 10208645|1051015 |
| D010672 | Phenytoin | NR1I2 protein affects the reaction [Phenytoin results in increased expression of CYP2C9 mRNA] | 14600250 |
| D010672 | Phenytoin | Phenytoin results in increased activity of CYP2C9 protein | 19202563 |
| D010672 | Phenytoin | Phenytoin results in increased expression of CYP2C9 mRNA | 14600250 |
| D010672 | Phenytoin | CYP2C9 protein results in increased metabolism of Phenytoin | 15569425 |
| D010672 | Phenytoin | CYP2C9 protein results in increased metabolism of Phenytoin | 19952982 |
| C032279 | phthalic acid | [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of phthalic acid | 23545481 |
| C556557 | picoxystrobin | picoxystrobin results in decreased activity of CYP2C9 protein | 23611293 |
| D010894 | Piroxicam | CYP2C9 gene polymorphism affects the metabolism of Piroxicam | 11901091 |
| D010894 | Piroxicam | CYP2C9 protein results in increased metabolism of Piroxicam | 11901091|1246424 |
| D010894 | Piroxicam | Piroxicam inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D010936 | Plant Extracts | Plant Extracts results in decreased activity of CYP2C9 protein | 15992226|2082860 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of CYP2C9 mRNA | 19041297|2355793 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of CYP2C9 protein | 19041297 |
| D010936 | Plant Extracts | Plant Extracts results in decreased activity of CYP2C9 protein | 16033948 |
| D028321 | Plant Preparations | Plant Preparations results in decreased activity of CYP2C9 protein | 26530625 |
| D028321 | Plant Preparations | Plant Preparations results in increased expression of CYP2C9 mRNA | 26530625 |
| C047681 | pranlukast | pranlukast inhibits the reaction [CYP2C9 protein results in increased metabolism of Tolbutamide] | 15370959 |
| C047681 | pranlukast | pranlukast results in decreased activity of CYP2C9 protein | 15370959 |
| C024273 | profenofos | profenofos inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] | 22634058 |
| C024273 | profenofos | profenofos results in decreased activity of CYP2C9 protein | 22634058 |
| D011374 | Progesterone | "NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2C9 mRNA]]" | 21768169 |
| D011374 | Progesterone | NR1I3 mutant form inhibits the reaction [Progesterone inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA]] | 21768169 |
| D011374 | Progesterone | "[Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]]" | 21768169 |
| D011374 | Progesterone | "[Progesterone co-treated with Estradiol] inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2C9 mRNA]" | 21768169 |
| D011374 | Progesterone | [Progesterone co-treated with Estradiol] inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA] | 21768169 |
| D011374 | Progesterone | "Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime promotes the reaction [[NR1I3 protein co-treated with FOXO1 protein co-treated with HNF4A protein co-treated with NCOA1 protein] binds to CYP2C9 promoter]]" | 21768169 |
| D011374 | Progesterone | "Progesterone inhibits the reaction [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased expression of CYP2C9 mRNA]" | 21768169 |
| D011374 | Progesterone | Progesterone inhibits the reaction [Phenobarbital results in increased expression of CYP2C9 mRNA] | 21768169 |
| C005556 | propionaldehyde | propionaldehyde results in decreased expression of CYP2C9 mRNA | 26079696 |
| D011433 | Propranolol | CYP2C9 protein results in increased oxidation of Propranolol | 19853591 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [2-tert-butylhydroquinone results in increased expression of CYP2C9 mRNA] | 24830941 |
| C030984 | pyrene | CYP2C9 protein affects the hydroxylation of pyrene | 15044613 |
| D011739 | Pyrimethamine | Pyrimethamine results in decreased activity of CYP2C9 protein | 11124226 |
| D011794 | Quercetin | Quercetin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Flurbiprofen] | 21053930 |
| D011794 | Quercetin | Quercetin inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D011794 | Quercetin | Quercetin results in decreased activity of CYP2C9 protein | 18420780 |
| D011794 | Quercetin | Quercetin results in increased expression of CYP2C9 mRNA | 21632981 |
| D011802 | Quinidine | Quinidine results in decreased activity of CYP2C9 protein | 18420780 |
| D011803 | Quinine | Quinine inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D011803 | Quinine | Quinine results in decreased activity of CYP2C9 protein | 11124226 |
| C523099 | rabeprazole-thioether | rabeprazole-thioether inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Diclofenac] | 15258107 |
| C059514 | resveratrol | resveratrol inhibits the reaction [CYP2C9 protein results in increased metabolism of Losartan] | 20716633 |
| C059514 | resveratrol | resveratrol results in decreased activity of CYP2C9 protein | 18420780 |
| C020491 | rhein | rhein results in decreased activity of CYP2C9 protein | 27633141 |
| D012293 | Rifampin | Ketoconazole inhibits the reaction [Rifampin results in increased expression of CYP2C9 mRNA] | 16608920 |
| D012293 | Rifampin | NCOA6 promotes the reaction [Rifampin promotes the reaction [[HNF4A co-treated with NR1I2] results in increased expression of CYP2C9 mRNA]] | 21292004 |
| D012293 | Rifampin | NR1I2 protein affects the reaction [Rifampin results in increased expression of CYP2C9 mRNA] | 14600250 |
| D012293 | Rifampin | Rifampin promotes the reaction [[HNF4A co-treated with NCOA6] results in increased expression of CYP2C9 mRNA] | 21292004 |
| D012293 | Rifampin | Rifampin promotes the reaction [[HNF4A co-treated with NR1I2] results in increased expression of CYP2C9 mRNA] | 21292004 |
| D012293 | Rifampin | Rifampin promotes the reaction [NR1I2 protein results in increased expression of CYP2C9 mRNA] | 21292004 |
| D012293 | Rifampin | Rifampin results in increased activity of and results in increased expression of CYP2C9 protein | 19202563 |
| D012293 | Rifampin | Rifampin results in increased activity of CYP2C9 protein | 14722322|1949736 |
| D012293 | Rifampin | Rifampin results in increased expression of and results in increased activity of CYP2C9 protein | 14709624|1580238 |
| D012293 | Rifampin | Rifampin results in increased expression of CYP2C9 mRNA | 14600250|1472232 |
| D012293 | Rifampin | Rifampin results in increased expression of CYP2C9 protein | 17590308|1904129 |
| D012293 | Rifampin | Rifampin results in increased expression of CYP2C9 | 19445531 |
| D019438 | Ritonavir | Ritonavir results in increased activity of CYP2C9 protein | 19202563 |
| D019438 | Ritonavir | Ritonavir results in increased expression of CYP2C9 mRNA | 11918509 |
| D020280 | Sertraline | CYP2C9 protein results in decreased methylation of and results in increased metabolism of Sertraline | 15547048 |
| D020280 | Sertraline | Sertraline inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| C016101 | shikonin | shikonin results in decreased activity of CYP2C9 protein | 28941798 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of CYP2C9 mRNA | 25895662 |
| C440975 | silybin | silybin results in decreased activity of CYP2C9 protein | 15155549 |
| D019821 | Simvastatin | Simvastatin affects the reaction [CYP2C9 polymorphism affects the susceptibility to Warfarin] | 22594507 |
| D020123 | Sirolimus | Sirolimus results in decreased expression of CYP2C9 protein | 25929522 |
| D020123 | Sirolimus | Sirolimus results in increased expression of CYP2C9 mRNA | 25929522 |
| C106276 | sitaxsentan | sitaxsentan inhibits the reaction [CYP2C9 protein results in increased metabolism of Diclofenac] | 23721565 |
| C001873 | sporidesmin | sporidesmin results in increased expression of CYP2C9 mRNA | 28193462 |
| C012042 | steviol | steviol binds to and results in decreased activity of CYP2C9 protein | 28887089 |
| C012043 | stevioside | stevioside results in decreased expression of CYP2C9 mRNA | 28887089 |
| C024075 | styrofoam | styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP2C9 protein] | 19909766 |
| C024075 | styrofoam | styrofoam analog results in decreased activity of CYP2C9 protein | 19909766 |
| D013411 | Sulfadiazine | CYP2C9 protein results in increased hydroxylation of Sulfadiazine | 15843491 |
| D013420 | Sulfamethoxazole | CYP2C9 protein results in increased oxidation of Sulfamethoxazole | 25170804 |
| D013420 | Sulfamethoxazole | [CYP2C9 protein results in increased oxidation of Sulfamethoxazole] which results in increased chemical synthesis of sulfamethoxazole hydroxylamine | 25170804 |
| C059873 | sulfamethoxazole hydroxylamine | CYP2C9 protein results in increased chemical synthesis of sulfamethoxazole hydroxylamine | 25170804 |
| C059873 | sulfamethoxazole hydroxylamine | [CYP2C9 protein results in increased oxidation of Sulfamethoxazole] which results in increased chemical synthesis of sulfamethoxazole hydroxylamine | 25170804 |
| D013426 | Sulfaphenazole | Sulfaphenazole inhibits the reaction [CYP2C9 protein affects the hydroxylation of Tolbutamide] | 9004453 |
| D013426 | Sulfaphenazole | CYP2C9 protein results in increased metabolism of Sulfaphenazole | 17702393|1930915 |
| D013426 | Sulfaphenazole | Sulfaphenazole inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D013426 | Sulfaphenazole | Sulfaphenazole inhibits the reaction [[CYP2C9 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 4'-hydroxydiclofenac] | 24246759 |
| D013426 | Sulfaphenazole | "Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased chemical synthesis of 11,12-epoxy-5,8,14-eicosatrienoic acid]" | 12675279 |
| D013426 | Sulfaphenazole | "Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased chemical synthesis of 14,15-epoxy-5,8,11-eicosatrienoic acid]" | 12675279 |
| D013426 | Sulfaphenazole | "Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased chemical synthesis of 8,9-epoxyeicosatrienoic acid]" | 12675279 |
| D013426 | Sulfaphenazole | Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased hydrolysis of Tolbutamide] | 11377097 |
| D013426 | Sulfaphenazole | "Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased metabolism of 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide]" | 19697924 |
| D013426 | Sulfaphenazole | Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased metabolism of Arachidonic Acid] | 12675279 |
| D013426 | Sulfaphenazole | Sulfaphenazole inhibits the reaction [[CYP2C9 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein] | 23850985 |
| D013426 | Sulfaphenazole | Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased metabolism of Diclofenac] | 12569440|2811916 |
| D013426 | Sulfaphenazole | Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased metabolism of Tolbutamide] | 23850985 |
| D013426 | Sulfaphenazole | Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased oxidation of 2-oxo-clopidogrel] | 19812348 |
| D013426 | Sulfaphenazole | Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased susceptibility to Cyclophosphamide] | 10991840 |
| D013426 | Sulfaphenazole | Sulfaphenazole results in decreased activity of CYP2C9 protein | 12464242|1246791 |
| D013426 | Sulfaphenazole | [Sulfaphenazole results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 22447115|2659997 |
| D013426 | Sulfaphenazole | Sulfaphenazole results in decreased expression of CYP2C9 mRNA | 24519941 |
| D013426 | Sulfaphenazole | Sulfaphenazole results in decreased activity of CYP2C9 protein | 10828259|1694598 |
| D013442 | Sulfinpyrazone | Sulfinpyrazone inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D013453 | Sulfonylurea Compounds | CYP2C9 gene polymorphism affects the susceptibility to Sulfonylurea Compounds | 19715737 |
| D014284 | Triiodothyronine | Triiodothyronine promotes the reaction [CYP2C9 protein results in increased metabolism of Coumarins] | 14557374 |
| D013629 | Tamoxifen | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Tamoxifen | 23397584 |
| D013629 | Tamoxifen | Tamoxifen metabolite results in increased activity of CYP2C9 protein | 29285606 |
| D013629 | Tamoxifen | Tamoxifen results in decreased activity of CYP2C9 protein | 18420780 |
| D000068698 | Tenofovir | Tenofovir results in decreased activity of CYP2C9 protein | 17162464 |
| D013739 | Testosterone | CYP2C9 protein affects the metabolism of Testosterone | 16648389 |
| D013739 | Testosterone | Testosterone results in decreased activity of CYP2C9 protein | 18420780 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CYP2C9 mRNA | 16985168 |
| D013827 | Thiabendazole | Thiabendazole results in decreased activity of CYP2C9 protein | 11124226 |
| C109005 | thiocoraline | CYP2C9 protein affects the metabolism of thiocoraline | 15122071 |
| D008063 | Thioctic Acid | Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D013881 | Thioridazine | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Thioridazine | 23397584 |
| D013881 | Thioridazine | Thioridazine results in decreased activity of CYP2C9 protein | 15135088 |
| D013988 | Ticlopidine | CYP2C9 protein results in increased oxidation of and results in increased cleavage of Ticlopidine metabolite | 19170597 |
| D013989 | Ticrynafen | CYP2C9 protein affects the metabolism of Ticrynafen | 21321060 |
| D013989 | Ticrynafen | CYP2C9 protein results in increased metabolism of Ticrynafen | 12464242 |
| D013989 | Ticrynafen | CYP2C9 protein results in increased susceptibility to Ticrynafen | 28762043 |
| D013989 | Ticrynafen | Ticrynafen inhibits the reaction [CYP2C9 protein results in increased metabolism of Diclofenac] | 16049126 |
| D013989 | Ticrynafen | Ticrynafen results in decreased activity of CYP2C9 protein | 15860655|1604912 |
| D013989 | Ticrynafen | CYP2C9 protein results in increased metabolism of Ticrynafen | 22329513 |
| D013989 | Ticrynafen | CYP2C9 protein results in increased oxidation of Ticrynafen analog | 22329513 |
| D013989 | Ticrynafen | Ticrynafen metabolite binds to and results in decreased activity of CYP2C9 protein | 22329513 |
| D014044 | Tolbutamide | CYP2C9 protein affects the hydroxylation of Tolbutamide | 9004453 |
| D014044 | Tolbutamide | Diclofenac inhibits the reaction [CYP2C9 protein affects the hydroxylation of Tolbutamide] | 9004453 |
| D014044 | Tolbutamide | Flurbiprofen inhibits the reaction [CYP2C9 protein affects the hydroxylation of Tolbutamide] | 9004453 |
| D014044 | Tolbutamide | Ketoprofen inhibits the reaction [CYP2C9 protein affects the hydroxylation of Tolbutamide] | 9004453 |
| D014044 | Tolbutamide | Phenylbutazone inhibits the reaction [CYP2C9 protein affects the hydroxylation of Tolbutamide] | 9004453 |
| D014044 | Tolbutamide | Sulfaphenazole inhibits the reaction [CYP2C9 protein affects the hydroxylation of Tolbutamide] | 9004453 |
| D014044 | Tolbutamide | Acetone promotes the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] | 10611138 |
| D014044 | Tolbutamide | acetonitrile promotes the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] | 10611138 |
| D014044 | Tolbutamide | CYP2C9 gene mutant form inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] | 25994031|2599403 |
| D014044 | Tolbutamide | CYP2C9 gene polymorphism affects the metabolism of Tolbutamide | 15045499 |
| D014044 | Tolbutamide | CYP2C9 gene polymorphism results in decreased metabolism of Tolbutamide | 10208645|9110362 |
| D014044 | Tolbutamide | CYP2C9 gene SNP affects the metabolism of Tolbutamide | 11875364|1242652 |
| D014044 | Tolbutamide | CYP2C9 gene SNP results in decreased hydroxylation of Tolbutamide | 9170147 |
| D014044 | Tolbutamide | CYP2C9 protein affects the hydroxylation of Tolbutamide | 9170147 |
| D014044 | Tolbutamide | CYP2C9 protein affects the metabolism of Tolbutamide | 11875364|1242652 |
| D014044 | Tolbutamide | CYP2C9 protein binds to and affects the metabolism of Tolbutamide | 15856409 |
| D014044 | Tolbutamide | CYP2C9 protein results in increased chemical synthesis of Tolbutamide metabolite | 23850985 |
| D014044 | Tolbutamide | CYP2C9 protein results in increased hydrolysis of Tolbutamide | 11377097 |
| D014044 | Tolbutamide | CYP2C9 protein results in increased hydroxylation of Tolbutamide | 10611138|1243379 |
| D014044 | Tolbutamide | CYP2C9 protein results in increased metabolism of Tolbutamide | 10208645|1246424 |
| D014044 | Tolbutamide | Fenitrothion inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] | 22634058 |
| D014044 | Tolbutamide | Malathion inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] | 22634058 |
| D014044 | Tolbutamide | phenthoate inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] | 22634058 |
| D014044 | Tolbutamide | pranlukast inhibits the reaction [CYP2C9 protein results in increased metabolism of Tolbutamide] | 15370959 |
| D014044 | Tolbutamide | profenofos inhibits the reaction [CYP2C9 protein results in increased hydroxylation of Tolbutamide] | 22634058 |
| D014044 | Tolbutamide | Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased hydrolysis of Tolbutamide] | 11377097 |
| D014044 | Tolbutamide | Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased metabolism of Tolbutamide] | 23850985 |
| D014044 | Tolbutamide | Tolbutamide inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D014044 | Tolbutamide | zafirlukast inhibits the reaction [CYP2C9 protein results in increased metabolism of Tolbutamide] | 15370959 |
| C026116 | torsemide | CYP2C9 protein results in increased hydroxylation of torsemide | 9110362 |
| C026116 | torsemide | CYP2C9 protein results in increased metabolism of torsemide | 19082874 |
| C507866 | trans-1,2-dihydro-1,2-naphthalenediol | "CYP2C9 protein results in increased abundance of trans-1,2-dihydro-1,2-naphthalenediol" | 16243959 |
| C542064 | trantinterol | trantinterol results in decreased activity of CYP2C9 protein | 21466844 |
| D014191 | Tranylcypromine | Tranylcypromine affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] | 24120545 |
| D014212 | Tretinoin | CYP2C9 protein results in increased hydroxylation of Tretinoin | 10874126 |
| D014212 | Tretinoin | Tretinoin results in decreased activity of CYP2C9 protein | 18420780 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of CYP2C9 mRNA | 16985168 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in increased expression of CYP2C9 mRNA" | 24407104 |
| C057693 | troglitazone | [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to troglitazone | 23397584 |
| C057693 | troglitazone | troglitazone results in decreased activity of CYP2C9 protein | 12642470 |
| D014363 | Tryptamines | Tryptamines analog results in decreased activity of CYP2C9 protein | 26599973 |
| D014363 | Tryptamines | [Tryptamines analog results in decreased activity of CYP2C9 protein] which results in decreased metabolism of Diclofenac | 26599973 |
| D014635 | Valproic Acid | CYP2C9 polymorphism results in increased susceptibility to Valproic Acid | 20398172 |
| D014635 | Valproic Acid | CYP2C9 protein results in increased metabolism of Valproic Acid | 16945988|2060262 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of CYP2C9 mRNA | 29154799 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of CYP2C9 mRNA | 25084468 |
| D014700 | Verapamil | Verapamil results in decreased activity of CYP2C9 protein | 18420780 |
| D014750 | Vincristine | CYP2C9 gene SNP results in increased susceptibility to Vincristine | 21245421 |
| D002762 | Cholecalciferol | Cholecalciferol metabolite results in increased expression of CYP2C9 | 11991950 |
| D002762 | Cholecalciferol | Cholecalciferol results in decreased activity of CYP2C9 protein | 18420780 |
| D065819 | Voriconazole | CYP2C9 protein affects the metabolism of Voriconazole | 15914520 |
| D065819 | Voriconazole | Voriconazole results in decreased activity of CYP2C9 protein | 15328084|1591452 |
| D065819 | Voriconazole | Voriconazole results in decreased activity of CYP2C9 protein | 16556082 |
| D014859 | Warfarin | 10-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin] | 20429590 |
| D014859 | Warfarin | 4'-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin] | 20429590 |
| D014859 | Warfarin | 6-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin] | 20429590 |
| D014859 | Warfarin | 7-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 6-hydroxywarfarin] | 20429590 |
| D014859 | Warfarin | 8-hydroxywarfarin inhibits the reaction [[CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin] | 20429590 |
| D014859 | Warfarin | Benzbromarone inhibits the reaction [CYP2C9 protein affects the metabolism of Warfarin] | 10613612 |
| D014859 | Warfarin | CYP2C9 affects the susceptibility to Warfarin | 22907842 |
| D014859 | Warfarin | CYP2C9 enhancer polymorphism affects the metabolism of Warfarin | 17332144 |
| D014859 | Warfarin | CYP2C9 gene affects the metabolism of Warfarin | 11307788 |
| D014859 | Warfarin | CYP2C9 gene affects the susceptibility to Warfarin | 11127854|1130778 |
| D014859 | Warfarin | CYP2C9 gene mutant form affects the susceptibility to Warfarin | 20354686|2126118 |
| D014859 | Warfarin | CYP2C9 gene mutant form results in increased susceptibility to Warfarin | 25994031|2625566 |
| D014859 | Warfarin | CYP2C9 gene polymorphism affects the abundance of Warfarin | 25986145 |
| D014859 | Warfarin | CYP2C9 gene polymorphism affects the hydrolysis of Warfarin | 9698079 |
| D014859 | Warfarin | CYP2C9 gene polymorphism affects the metabolism of Warfarin | 12621390 |
| D014859 | Warfarin | CYP2C9 gene polymorphism affects the susceptibility to and affects the metabolism of Warfarin | 26469104 |
| D014859 | Warfarin | CYP2C9 gene polymorphism affects the susceptibility to Warfarin | 14656880|1469157 |
| D014859 | Warfarin | CYP2C9 gene polymorphism results in decreased hydroxylation of Warfarin | 11455026 |
| D014859 | Warfarin | CYP2C9 gene polymorphism results in decreased metabolism of Warfarin | 20073138 |
| D014859 | Warfarin | CYP2C9 gene polymorphism results in decreased susceptibility to Warfarin | 18030307|1803461 |
| D014859 | Warfarin | CYP2C9 gene polymorphism results in increased susceptibility to Warfarin | 11794436|1989932 |
| D014859 | Warfarin | CYP2C9 gene SNP affects the susceptibility to Warfarin | 20442691|2065367 |
| D014859 | Warfarin | CYP2C9 polymorphism affects the susceptibility to Warfarin | 17510308|1789550 |
| D014859 | Warfarin | CYP2C9 protein affects the hydroxylation of Warfarin | 10613612 |
| D014859 | Warfarin | CYP2C9 protein affects the metabolism of Warfarin | 14586384|1467682 |
| D014859 | Warfarin | CYP2C9 protein affects the susceptibility to Warfarin | 15952022|1745682 |
| D014859 | Warfarin | CYP2C9 protein polymorphism affects the susceptibility to Warfarin | 23800980|2460197 |
| D014859 | Warfarin | CYP2C9 protein results in increased hydrolysis of Warfarin | 9698079 |
| D014859 | Warfarin | CYP2C9 protein results in increased hydroxylation of Warfarin | 11455026|1243379 |
| D014859 | Warfarin | [CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 6-hydroxywarfarin | 20429590 |
| D014859 | Warfarin | [CYP2C9 protein results in increased hydroxylation of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin | 20429590 |
| D014859 | Warfarin | CYP2C9 protein results in increased metabolism of Warfarin | 12464242|1687844 |
| D014859 | Warfarin | [CYP2C9 protein results in increased metabolism of Warfarin] which results in increased chemical synthesis of 6-hydroxywarfarin | 19408964 |
| D014859 | Warfarin | [CYP2C9 protein results in increased metabolism of Warfarin] which results in increased chemical synthesis of 7-hydroxywarfarin | 19408964 |
| D014859 | Warfarin | CYP2C9 protein results in increased susceptibility to Warfarin | 17049586|1711119 |
| D014859 | Warfarin | CYP2C9 results in increased susceptibility to Warfarin | 20420818 |
| D014859 | Warfarin | CYP2C9 SNP affects the susceptibility to Warfarin | 24966969|2807979 |
| D014859 | Warfarin | CYP2C9 SNP affects the susceptibility to Warfarin analog | 25499099 |
| D014859 | Warfarin | Simvastatin affects the reaction [CYP2C9 polymorphism affects the susceptibility to Warfarin] | 22594507 |
| D014859 | Warfarin | [Warfarin binds to and results in increased activity of NR1I2 protein] which results in increased expression of CYP2C9 mRNA | 20735727 |
| D014859 | Warfarin | Warfarin inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| D014859 | Warfarin | Warfarin results in decreased activity of CYP2C9 protein | 18420780 |
| D014859 | Warfarin | CYP2C9 protein affects the hydroxylation of Warfarin | 15044613 |
| D014859 | Warfarin | CYP2C9 protein affects the metabolism of Warfarin | 18763667 |
| C062735 | zafirlukast | zafirlukast inhibits the reaction [CYP2C9 protein affects the metabolism of Diclofenac] | 16081671 |
| C062735 | zafirlukast | zafirlukast inhibits the reaction [CYP2C9 protein results in increased metabolism of Tolbutamide] | 15370959 |
| C062735 | zafirlukast | zafirlukast results in decreased activity of CYP2C9 protein | 15370959 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of CYP2C9 mRNA | 24714768 |